Quick Dispatch:
Your surpass trial tirzepatide Media Centre orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your surpass trial tirzepatide Media Centre ships.
Need Help?
Questions about surpass trial tirzepatide Media Centre, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for surpass trial tirzepatide Media Centre in your area.
Flow of Participants in the SURPASS-6 Trial See Table 3 for the details...
23.08
SURPASS-CVOT trial: For patients with high-risk type 2 diabetes, the effect of tirzepatide, a dual agonist of the GLP-1 and glucose-dependent insulinotropic polypeptide receptors, on cardiovascular outcomes is uncertain. Research is summarized
23.37
Full article: An update on tirzepatide for the management of type 2 diabetes: a focus on the phase 3 clinical development program
28.38
SURPASS-CVOT Shows Mounjaro Surpasses Trulicity in CV Outcomes
23.56
01443-4/asset/63fe4912-d57e-4c87-ad6b-1952000f93e1/main.assets/gr1_lrg.jpg)
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
22.52
Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity
26.55
Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice
28.42
